BioCirc Group Holding ApS financials

BioCirc Group Holding ApS

Country: DK Reporting currency: DKK Latest annual report: 2025-12-31
LEI: 6488Q23W7VZS28N14E98
Source filing ↗
Financial statements (DKK, as reported — unscaled; 88 line items across 2 annual periods)
Line item 20252024
Income statement
Revenue DKK 1.75BDKK 1.48B
Gross profit DKK 844.6MDKK 802.1M
Other income DKK 25.9MDKK 10.1M
Employee benefits expense DKK 202.1MDKK 163.4M
Raw materials & consumables used DKK 936.0MDKK 726.1M
Operating profit (EBIT) -DKK 30.0M-DKK 148.1M
Finance costs DKK 87.4MDKK 100.1M
Profit before tax -DKK 116.2M-DKK 241.8M
Income tax expense -DKK 20.7M-DKK 46.3M
Profit for the year -DKK 95.5M-DKK 195.5M
— attributable to owners -DKK 95.5M-DKK 195.5M
Total comprehensive income -DKK 90.7M-DKK 195.5M
Cash flow statement
Net cash from operating activities DKK 84.8M-DKK 4.8M
Income taxes paid DKK 900.0KDKK 8.0M
Net cash from investing activities -DKK 633.2M-DKK 826.6M
Purchase of PP&E (capex) DKK 690.0MDKK 404.0M
Purchase of intangibles DKK 0DKK 120.0M
Net cash from financing activities DKK 467.4MDKK 842.8M
Proceeds from borrowings DKK 310.2MDKK 266.9M
Repayments of borrowings DKK 137.4MDKK 267.2M
Lease liability payments DKK 33.6MDKK 24.1M
Balance sheet
Total assets DKK 5.85BDKK 5.50B
Non-current assets DKK 5.19BDKK 4.78B
Property, plant & equipment DKK 3.67BDKK 3.27B
Right-of-use assets DKK 184.0MDKK 138.6M
Intangible assets & goodwill DKK 1.33BDKK 1.38B
Current assets DKK 664.4MDKK 715.4M
Inventories DKK 153.3MDKK 151.5M
Trade & other receivables DKK 214.4MDKK 200.7M
Cash & equivalents DKK 163.0MDKK 244.0M
Total equity DKK 3.19BDKK 2.95B
— attributable to owners DKK 3.19BDKK 2.95B
Non-current liabilities DKK 2.03BDKK 2.02B
Lease liabilities (non-current) DKK 139.6MDKK 105.9M
Current liabilities DKK 632.5MDKK 522.1M
Lease liabilities (current) DKK 28.2MDKK 22.1M
Deferred tax liabilities DKK 217.6MDKK 238.2M
Derived metrics
Free cash flow -DKK 605.2M-DKK 408.8M
Operating margin -1.7%-10.0%
Net margin -5.4%-13.2%
Return on equity -3.0%-6.6%
Cash conversion ratio -0.89×0.02×
Capex coverage 0.12×-0.01×
Other reported items
Adjustments For Reconcile Profit Loss DKK 16.4MDKK 4.8M
Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities DKK 0DKK 167.5M
Changes In Inventories of Finished Goods and Work In Progress -DKK 1.8M-DKK 37.4M
Construction In Progress DKK 582.2MDKK 351.5M
Current Contract Assets DKK 6.7MDKK 0
Current Contract Liabilities DKK 0DKK 49.4M
Current Loans Received and Current Portion of Noncurrent Loans Received DKK 296.0MDKK 134.2M
Current Prepayments DKK 12.1MDKK 57.2M
Deferred Income Other Than Contract Liabilities DKK 15.2MDKK 8.9M
Depreciation Amortisation and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss DKK 281.6MDKK 220.2M
Equity and Liabilities DKK 5.85BDKK 5.50B
Finance Costs Paid Classified As Operating Activities DKK 75.6MDKK 100.1M
Finance Income DKK 1.2MDKK 6.4M
Finance Income Received Classified As Operating Activities DKK 1.2MDKK 6.4M
Fixtures and Fittings DKK 124.1MDKK 40.8M
Increase Decrease In Cash and Cash Equivalents -DKK 81.0MDKK 11.4M
Increase Decrease In Working Capital DKK 107.9M-DKK 20.0M
Increase Decrease Through Sharebased Payment Transactions DKK 1.3MDKK 4.8M
Increase Decrease Through Transactions With Owners DKK 329.4MDKK 401.4M
Intangible Assets Other Than Goodwill DKK 148.3MDKK 176.6M
Issue of Equity DKK 331.9MDKK 396.6M
Issued Capital DKK 14.1MDKK 12.5M
Land DKK 613.9MDKK 588.0M
Liabilities DKK 2.66BDKK 2.54B
Machinery DKK 2.35BDKK 2.29B
Noncurrent Deferred Income Including Noncurrent Contract Liabilities DKK 196.7MDKK 213.7M
Noncurrent Portion of Noncurrent Bonds Issued DKK 471.2MDKK 470.6M
Noncurrent Portion of Noncurrent Loans Received DKK 985.5MDKK 974.5M
Noncurrent Provisions DKK 16.3MDKK 19.6M
Other Adjustments For Noncash Items DKK 16.4MDKK 4.8M
Other Comprehensive Income DKK 4.8M
Other Comprehensive Income Net of Tax Exchange Differences On Translation DKK 4.8MDKK 0
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax DKK 4.8MDKK 0
Other Current Financial Assets DKK 114.9MDKK 62.0M
Other Expense By Nature DKK 390.9MDKK 566.6M
Other Noncurrent Financial Assets DKK 1.2MDKK 1.1M
Payments For Development Project Expenditure DKK 7.4MDKK 0
Proceeds From Issue of Bonds Notes and Debentures DKK 0DKK 470.6M
Proceeds From Issuing Shares DKK 331.9MDKK 396.6M
Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities DKK 64.2MDKK 12.2M
Purchase of Investments Other Than Investments Accounted For Using Equity Method DKK 0DKK 147.3M
Purchase of Treasury Shares DKK 3.7M
Reserve of Exchange Differences On Translation DKK 4.8MDKK 0
Retained Earnings DKK 3.17BDKK 2.94B
Trade and Other Current Payables To Trade Suppliers DKK 293.1MDKK 307.5M
Methodology

Every line item above is a fact tagged in BioCirc Group Holding ApS's annual report filed in the European Single Electronic Format (ESEF) under the IFRS taxonomy (ifrs-full) — the income statement, balance sheet and cash-flow statement as the filer reported them. Values are shown as-is, in the reporting currency (DKK), without rescaling; the row labels map to the underlying concept name (e.g. Revenue → ifrs-full:Revenue, Operating profit → ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS → ifrs-full:DilutedEarningsLossPerShare), and any concept without a curated label is shown under “Other reported items” with its de-camel-cased tag name. Only consolidated, default-member facts are shown (segment / dimensional breakdowns are excluded).

“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.

Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.